We also showed that endogenously expressed plakoglobin in the p53 null SKOV-3 mammary carcinoma cells interacted with exogenously expressed p53-175 and p53-273 mutants in these cells and resulted in a similar reduction of the invasive properties of both p53-mutants in SKOV-3 cells. This evidence concerns the gene TP53 and breast carcinoma.